EFC insider files: 9,198 restricted shares; 5,544 bought at $13.5599
Rhea-AI Filing Summary
Ronald I. Simon, a director of Ellington Financial Inc. (EFC), reported two transactions in September 2025. On September 10, 2025 he was issued 9,198 common shares under the companys 2017 Equity Incentive Plan at a $0 grant price; those shares remain forfeitable until September 9, 2026. On September 11, 2025 he purchased 5,544 common shares at $13.5599 per share, held in his personal broker retirement account. After these transactions the report lists 80,000 shares beneficially owned, primarily held indirectly in the Simon Family Trust, of which Dr. Simon is a trustee and for which he disclaims beneficial ownership except to the extent of his pecuniary interest.
Positive
- Director purchase of 5,544 shares at $13.5599 increases insider ownership
- Grant of 9,198 shares aligns director compensation with shareholder value via the 2017 Equity Incentive Plan
Negative
- 9,198 granted shares remain forfeitable until September 9, 2026, limiting immediate ownership rights
- Majority of holdings (80,000 shares) are held indirectly via the Simon Family Trust, reducing direct control disclosure
Insights
Director received 9,198 restricted shares and bought 5,544 shares at $13.5599.
The 9,198 shares granted on September 10, 2025 are subject to forfeiture until September 9, 2026, indicating they are restricted compensation under the 2017 Equity Incentive Plan. That means voting/transfer rights may be limited until vesting conditions lapse.
The 5,544 share purchase on September 11, 2025 at $13.5599 was made into a retirement account and increases Dr. Simons personal position. Monitor the September 9, 2026 forfeiture/vesting date for changes in beneficial ownership status.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 5,544 | $13.5599 | $75K |
| Grant/Award | Common Stock | 9,198 | $0.00 | -- |
Footnotes (1)
- The 9,198 shares of common stock, $0.001 par value per share (the "Common Shares") remain forfeitable, subject to the reporting person's continued service as a member of the board of directors of Ellington Financial Inc. (the "Company"), until September 9, 2026. The Common Shares were issued pursuant to, and are subject to the terms and conditions of the Company's 2017 Equity Incentive Plan. The 9,198 Common Shares issued to Dr. Simon on September 10, 2025 are held at the transfer agent of the Company. As of the date of issuance, other than the 9,198 shares issued to Dr. Simon and the 8,378 Common Shares that were previously issued to Dr. Simon on December 27, 2024, all of the remaining Common Shares held by Dr. Simon were held in the Simon Family Trust (the "Trust"). Dr. Simon is a trustee of the Trust. Dr. Simon and his wife are the beneficiaries of the Trust. Dr. Simon disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. The 5,544 Common Shares purchased by Dr. Simon on September 11, 2025 are held by his personal broker in an investment retirement account. As of the date of purchase, other than 5,544 shares purchased by Dr. Simon, the 9,198 shares granted on September 10, 2025, the 8,378 Common Shares that were previously issued to Dr. Simon on December 27, 2024, all of the remaining Common Shares held by Dr. Simon were held in the Simon Family Trust (the "Trust"). Dr. Simon is a trustee of the Trust. Dr. Simon and his wife are the beneficiaries of the Trust. Dr. Simon disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
